Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Takeda, Kyoto University Kick Off iPS Projects Targeting 6 Diseases
December 16, 2015
- LEO Pharma “Eager to Do More” after Astellas Deal to Expand Globally: CEO
December 16, 2015
- JPO Says Patents for Alimta Vitamin Therapy Valid until 2021
December 16, 2015
- Mitsubishi Tanabe Gains Exclusive Rights to Akebia’s Anemia Drug in Asia
December 16, 2015
- Mundipharma Poised to Expand Japan Operations by Tapping Isodine Brand: Asia Head
December 15, 2015
- Daiichi Sankyo Looking for a Partner to Codevelop GPR119 Agonist: CEO Nakayama
December 15, 2015
- GSK to Supply Tenozet by Imports from Gilead
December 15, 2015
- Astellas Joins Hands with US Biopharma Bellicum on Cancer Cell Therapy
December 14, 2015
- Novartis Submits Business Improvement Plan over ADR Reporting Delays
December 14, 2015
- ASKA to Launch Authorized Generics of Unisia in March
December 14, 2015
- Ono Files Opdivo for Kidney Cancer, Third Indication in Japan
December 14, 2015
- Mundipharma to Link Up with Shionogi on Isodine Brand, Dissolve Ties with Meiji Seika Pharma
December 11, 2015
- M&As among Generic Makers Would Reap No Benefits: Sawai President
December 11, 2015
- Sumitomo Dainippon to Launch 3 Pivotal Trials for Napabucasin in FY2015, Postpone BBI503 Program
December 10, 2015
- Sumitomo Dainippon to Begin Lurasidone PIII within FY2015, 3rd Attempt for Schizophrenia Indication
December 10, 2015
- Mitsubishi Chemical Holdings to Invest in New Production Facilities for Drugs and Vaccines
December 10, 2015
- Stephen Hitchcock Tapped as Head of Pharma Research at Takeda
December 9, 2015
- Takeda Ties Up with US Biotech Cour on Immune Modulating Therapies
December 9, 2015
- Ethical Drug Sales Zoom 10.7% in October: Crecon Report
December 9, 2015
- Mega Mergers Not the Best Way to Get Drug Discovery Prowess: Astellas President
December 9, 2015
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…